Zuzana Tothova, D. Gary Gilliland  Cell Stem Cell 

Slides:



Advertisements
Similar presentations
Normal and Leukemic Stem Cell Niches: Insights and Therapeutic Opportunities Koen Schepers, Timothy B. Campbell, Emmanuelle Passegué Cell Stem Cell Volume.
Advertisements

Hematopoietic Stem Cells Burn Fat to Prevent Exhaustion
FoxO: A New Addition to the ESC Cartel
Aspirin use and endometrial cancer risk and survival
ERRγ—A New Player in β Cell Maturation
All roads lead to FoxO Cell Metabolism
A Time to Divide: Does the Circadian Clock Control Cell Cycle?
A Radical Bailout Strategy for Cancer Stem Cells
Christopher Hine, James R. Mitchell  Cell Stem Cell 
Metabolic Makeover for HSCs
ROS Function in Redox Signaling and Oxidative Stress
Christa Buecker, Niels Geijsen  Cell Stem Cell 
Resistance in the Ribosome: RUNX1, pre-LSCs, and HSPCs
Christopher Hine, James R. Mitchell  Cell Stem Cell 
A Flt3L Encounter: mTOR Signaling in Dendritic Cells
Natalia J. Martinez, Richard I. Gregory  Cell Stem Cell 
ILCs and T Cells Competing for Space: More Than a Numbers Game
Stressed-Out HSCs Turn Up p38α and Purine to Proliferate
The marriage of glucose and blood vessels: It isn’t all that sweet
Volume 13, Issue 1, Pages 1-2 (January 2008)
Methed-Up FOXOs Can't In-Akt-ivate
Maria M. Mihaylova, David M. Sabatini, Ömer H. Yilmaz  Cell Stem Cell 
DNA-Damage Response in Tissue-Specific and Cancer Stem Cells
The Autistic Neuron: Troubled Translation?
MicroRNA Regulation of Stem Cell Fate
Foxo1 and Foxo3 help Foxp3 Immunity
PTEN Enters the Nuclear Age
Resistance in the Ribosome: RUNX1, pre-LSCs, and HSPCs
Life Is Short, if Sweet Cell Metabolism
p27 as a target for cancer therapeutics
Ashok Kumar Jayavelu, Jennifer N. Moloney, Frank-D. Böhmer, Thomas G
Autophagy: A Sweet Process in Diabetes
Ahmed Mohyeldin, Tomás Garzón-Muvdi, Alfredo Quiñones-Hinojosa 
Peter J. Barnes, FRS, FMedSci 
A New Therapeutic Target for Leukemia Comes to the Surface
Selective Insulin and Leptin Resistance in Metabolic Disorders
Silencing Insulin Resistance through SIRT1
Mohammad Abdul-Ghani, Lynn A. Megeney  Cell Stem Cell 
The RAS/MAPK Axis Gets Stressed Out
Long Noncoding RNA in Hematopoiesis and Immunity
Meddling with METTLs in Normal and Leukemia Stem Cells
A New FOXO Pathway Required for Leukemogenesis
Aspp1: A Guardian of Hematopoietic Stem Cell Integrity
Youry Kim, Jenny L. Anderson, Sharon R. Lewin  Cell Host & Microbe 
NOTCH and PI3K-AKT Pathways Intertwined
CDK Inhibitors: Cell Cycle Regulators and Beyond
Bryan Krock, Nicolas Skuli, M. Celeste Simon  Cell Metabolism 
Proteins Kinases: Chromatin-Associated Enzymes?
Regulation of Stem Cell Aging by Metabolism and Epigenetics
p38δ and PKD1: Kinase Switches for Insulin Secretion
Volume 19, Issue 5, Pages (September 2005)
Metabolic Homeostasis: HDACs Take Center Stage
Madeline Niederkorn, Daniel T. Starczynowski  Cell Stem Cell 
Long Noncoding RNAs in Cell-Fate Programming and Reprogramming
Volume 14, Issue 2, Pages (August 2011)
Alex Kentsis, A. Thomas Look  Cell Stem Cell 
Philip Cohen, Marianna Tcherpakov  Cell 
Khalid S. Mohammad, Theresa A. Guise  Cancer Cell 
Tailor Made Protein Synthesis for HSCs
Capturing Pluripotency
Abby Sarkar, Konrad Hochedlinger  Cell Stem Cell 
Selective Transcription in Response to an Inflammatory Stimulus
Macrophages, Immunity, and Metabolic Disease
Attacking Cancer at Its Root
Tenets of PTEN Tumor Suppression
PTENtiating CFTR for Antimicrobial Immunity
Successful targeting of ErbB2 receptors—is PTEN the key?
PTEN and p53: Who will get the upper hand?
Knocking the Wnt out of the Sails of Leukemia Stem Cell Development
Skp2, the FoxO1 hunter Cancer Cell
Presentation transcript:

FoxO Transcription Factors and Stem Cell Homeostasis: Insights from the Hematopoietic System  Zuzana Tothova, D. Gary Gilliland  Cell Stem Cell  Volume 1, Issue 2, Pages 140-152 (August 2007) DOI: 10.1016/j.stem.2007.07.017 Copyright © 2007 Elsevier Inc. Terms and Conditions

Figure 1 PI3K/AKT and Stress Stimuli-Mediated Pathways Regulate FoxO Function Activation of the PI3K/AKT pathway in response to insulin or growth factor stimulation results in recruitment and activation of the serine-threonine kinase AKT. Activated AKT inhibits FoxO function by phosphorylation of FoxOs at three conserved residues. The dual specificity lipid and protein phosphatase PTEN antagonizes PI3K/AKT activity. In the presence of stress stimuli, JNK phosphorylates FoxOs at a distinct set of threonine residues and mediates their nuclear import and transcriptional activation of stress resistance-inducing target genes. Similarly, presence of stress stimuli activates deacetylation of FoxOs by SIRT1 and monoubiquitination of FoxOs by E3 ligase, which both promote FoxO-mediated transcription of genes inducing stress resistance. Cell Stem Cell 2007 1, 140-152DOI: (10.1016/j.stem.2007.07.017) Copyright © 2007 Elsevier Inc. Terms and Conditions

Figure 2 PI3K/AKT/FoxO Signaling Is Highly Conserved across Species The C. elegans, D. melanogaster, and mammalian orthologs of FoxOs are highly conserved in their ability to mediate stress resistance and increase in lifespan as downstream effectors of the PI3K/AKT pathway. Cell Stem Cell 2007 1, 140-152DOI: (10.1016/j.stem.2007.07.017) Copyright © 2007 Elsevier Inc. Terms and Conditions

Figure 3 Antioxidant Treatment of FoxO-Deficient Mice Reverses Increased ROS Levels in the HSC Compartment and Restores Proper HSC Function Treatment of FoxO1/3/4-deficient animals with the antioxidant NAC restores levels of ROS, as well as proper functions in the HSC compartment, including HSC number, cell cycling, and apoptosis, and implicates ROS as the causal agent in the FoxO-deficient HSC phenotype. Cell Stem Cell 2007 1, 140-152DOI: (10.1016/j.stem.2007.07.017) Copyright © 2007 Elsevier Inc. Terms and Conditions

Figure 4 FoxO Regulation of ROS during Hematopoietic Development and Its Proposed Effects on Fate Determination and Longevity FoxO transcription factors may contribute to fate determination by providing compartmentalization of antioxidant enzymes. Under normal hematopoietic homeostasis, HSCs are some of the longest-lived cells as a result of their ability to maintain low levels of ROS. Decreased FoxO activity correlates with decreased FoxO-dependent antioxidant expression and increased ROS levels, which may act as the required signal directing the transition from HSCs to more mature fates. Loss of FoxOs results in a significant increase in ROS in the HSC compartment with a subsequent decrease in lifespan of these cells. (Artwork courtesy of Eric Smith.) Cell Stem Cell 2007 1, 140-152DOI: (10.1016/j.stem.2007.07.017) Copyright © 2007 Elsevier Inc. Terms and Conditions

Figure 5 FoxOs in Normal versus Malignant HSCs Genetic loss of FoxOs in the HSC compartment results in increased levels of ROS and loss of self-renewal of HSCs. Most, if not all, myeloid leukemias, including those mediated by BCR/ABL, are characterized by constitutive activation of the PI3K/AKT pathway with resultant posttranslational FoxO inactivation. It remains to be determined whether leukemic stem cells have increased levels of ROS and what mechanisms render their unlimited self-renewal potential in spite of predicted high levels of ROS. Cell Stem Cell 2007 1, 140-152DOI: (10.1016/j.stem.2007.07.017) Copyright © 2007 Elsevier Inc. Terms and Conditions

Figure 6 Proposed Model of FoxO Function in the Maintenance of the Integrity of HSC Compartment FoxOs maintain quiescence, enhance survival, and mediate resistance to physiologic oxidative stress and thereby maintain self-renewal of the HSC compartment. (All of the target genes in bold have been directly investigated in studies of FoxOs in HSCs to date, all of the target genes in regular font have been linked to FoxO function in previous studies, and all of the target genes with a question mark remain to be investigated as downstream targets of FoxOs that contribute to the maintenance of HSC self-renewal.) Cell Stem Cell 2007 1, 140-152DOI: (10.1016/j.stem.2007.07.017) Copyright © 2007 Elsevier Inc. Terms and Conditions